chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient experienced left arm was aching from the morning and in the evening, I decided to feel where the ache is and feel a bump; Patient experienced left arm was aching from the morning and in the evening, I decided to feel where the ache is and feel a bump; This is a spontaneous report from a contactable consumer. This 46-years-old female consumer (patient) reported for herself that: A 45-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 03Mar2021 at 11:00 (at the age of 45-year-old) as single dose for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included asthma from an unknown date and unknown if ongoing. Patient had allergy to shellfish and watermelon. Patient not diagnosed with covid-19 prior to vaccination. There were no concomitant medications. The patient previously took spironolactone and experienced drug allergy. Patient was not received any other vaccine four weeks prior vaccination and patient did not receive any medication two weeks prior vaccination. Patient experienced left arm was aching from the morning and in the evening, I decided to feel where the ache is and feel a bump on 11Mar2021 at 05:30. Since vaccination patient not tested for covid-19. No therapeutic measures were taken as a result of the events. The outcome of the events was reported as not recovered.   No follow-up attempts are possible. No further information is expected.
Information has been received from a medical assistant concerning a patient who on 15-JAN-2008 was vaccinated subcutaneous with a 0.65 ml full dose ("may have gotten") of ZOSTAVAX (Merck) minus one small drop.  It was also reported some of the vaccine dripped down the patient's arm.  No adverse event reported.  Teh patient sought medical attention via an office visit.  A product quality complaint was not involved.  Follow-up information received from the patient indicated her "shot may have been given intramuscular (IM) instead of subcutaneous".  Follow-up information was received from the patient.  The patient had been diagnosed with rheumatoid arthritis after getting ZOSTAVAX (Merck).  Additional information has been requested.
12/99, after 2nd dose of Hep-B series, for approx. 2 weeks, experienced jaundice, fever/chills and fatigue. Symptoms, except for jaundice, have recurred sporadically since the 1st episode. Also experiencing right upper quadrant abdominal pain.
This spontaneous report was received from a 78 year old female patient regarding herself. Patient's current condition included High blood pressure, high cholesterol and thyroid condition. The patient stated that sulfa (unspecified manufacturer) made her experienced an anaphylaxis reaction and she was admitted to an unspecified hospital for unspecified duration. On 19-SEP-2013, the patient was vaccinated with one dose of ZOSTAVAX (invalid lot # JC04268, expiry: 12-JUL-2014) for prevention of shingles. Concomitant therapies included LEVOTHYROID, METFORMIN and NEXIUM. On 21-SEP-2013, the patient experienced injection site reaction which included soreness, felt tender to touch, felt like it was swollen and her arm itched around the injection site. The patient also stated that after receiving the ZOSTAVAX she developed fever, woke up with dizziness and then could not focus, she felt like her bowels were "growling", could not go to the bathroom, had difficulty eating and swallowing, had an odd feeling in the back of her throat and mouth, broke out into a sweat, felt very light headed, and developed a headache. Patient sought medical attention contacted the pharmacist by phone. Patient took aspirin (unspecified manufacturer) as treatment. Bloodwork and lipid testing were performed (results not reported). The outcome of the events were reported as not recovered. Additional information has been requested.
Swollen lymph nodes, body aches, chills, malaise x 4 days
GRAND MAL SEIZURE; This spontaneous report received from a parent concerned a patient of 19-year-old female. The patient's weight was 210 pounds, and height was 170 centimeters. The patient's past medical history included seizures, drop blood pressure, and pulse drop, and concurrent conditions included borderline personality, bipolar disorder, cigarette smoker, non-alcohol user, marijuana user, and memory loss, and other pre-existing medical conditions included patient had no known allergies. The patient had no drug abuse/illicit drug use.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, 1 total administered on 03-JUN-2021 to right deltoid for prophylactic vaccination. No concomitant medications were reported.  On 03-JUN-2021, at 7 pm the patient complained of being very tired, she felt that she was passing out and nauseated. At 3 am in morning (04-JUN-2021), patient started to have a grand mal seizure, lied on the floor, totally confused, her eyes went all over the place, she did not remember all the people around her. Based on description patient had memory loss, she could not remember the last 3 years of her life and she was on year between 2017 and 2018. Patient had a history of seizure last 2017 when she was on a psychotropic medication (Topamax) which she was taking because of her bipolar disorder. Medication which was taken for bipolar disorder causes her to drop her blood pressure and pulse which resulted to seizure. Patient was planning to visit doctor. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from grand mal seizure. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210611850-COVID-19 VACCINE AD26.COV2.S-Grandmal seizure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE
Patient was in pharmacy to receive TDAP vaccine, she was mixed up with another patient and was given a dose of Pfizer Covid 19 vaccine instead. She had previously received 2 doses of Moderna Covid vaccine plus 1 booster dose of Moderna finishing 2 months prior.  Patient experienced anxiety but no immediate threats to health. She was monitored for 10 minutes and at that time she elected to go to Dr's office for follow up.
First injection resulted in Nose Blead overnight and significant bleeding of the gums the second day resolved by the third day without treatment Second injection likely caused delayed reaction 17 days later,  Significant swollen upper lip . Will seek medical attention when EMO opens
first dose in October 2019, has not received second; swelling in arm; redness in arm; itchiness in arm; pain in arm; This case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced swelling arm, erythema of extremities, itchy upper limbs, pain in arm and incomplete course of vaccination. On an unknown date, the outcome of the swelling arm, erythema of extremities, itchy upper limbs and pain in arm were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the swelling arm, erythema of extremities, itchy upper limbs and pain in arm to be related to Shingrix.   Additional Information: GSK Receipt Date: 8-JUN-2022 Reporter's Comment: The patient self-reported this case. The patient received dose of Shingrix vaccine into the left arm and experienced swelling, redness, itchiness and pain in her left arm within 24 hours of receiving her first dose. The patient reported that the above symptoms were resolved after one month. The patient also stated that she had not received her second dose but planed on getting it soon (Inappropriate schedule of vaccine). The reporter did not consent to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
MD visit 7JUL94 c/o intense local react shortly p/administration; this react resolved over a few days but pt devel joint pain in lt shoulder, elbow & wrist persisting through 7JUL94; PE unremarkable;
Reports pain with lifting of (Lt) arm since date of receiving vaccine. Approx. 3 hrs. after receiving vaccine, had severe pain x 5 days, has since diminished but still feels dull pain which radiates to elbow. No treatment sought.
Pt rcvd Dtap on 2/26/07 came in 72 hours later 3-1-07 with red raised area about 76 MM
pt recv vax 29JUL98 & pt exp neck stiffness, vertigo, disturbed sleep, visual disturbances & pain that radiates down back (muscle pain);
ABOUT 16 HOURS AFTER SHOT I STARTED DEVELOPING A SERIES NECK ACHE WHICH TURNED INTO A VERY STIFF NECK AND AND HEADACHE.  IT'S BEEN MORE THAN 48 HOURS NOW SINCE START OF PROBLEM.  THINGS SEEM TO BE GETTING BETTER BUT STILL HAVE LIMITED MOBILITY WITHOUT PAIN.
Mild to moderate pain at the injection site; Muscle aches in legs and arms; Mild headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Feb2021 at 13:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included bicuspid aortic valve and pre-hypertension. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included propanolol (MANUFACTURER UNKNOWN) 20 mg twice daily (BID) and losartan (MANUFACTURER UNKNOWN) 50 mg four times daily (QD); both from unknown date, for unknown indications and unknown if ongoing. On 25Feb2021, the patient experienced mild to moderate pain at the injection site, muscle aches in legs and arms and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild to moderate pain at the injection site, muscle aches in legs and arms and mild headache was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Wife called clinic 10/03/03.  Reports 2 and half hours after flu vaccine patient c/o, n/v, bpv.  Symptoms not improved next day, instructed patient to see PMD ASAP.  Patient went to hospital from residence 10/4/03 via ambulence, expired that night.
Headache; achy joints; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of an unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 47 years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced headache and achy joints. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events headache and achy joints was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from the patient's mother and refers to a five and half year old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was administered M-M-R II (dose, anatomical location, route of administration, lot #, therapy type, and expiration date were not reported) or an unspecified polio vaccine by an unspecified nurse. The physician's office informed the patient's mother that the chart was incorrectly marked as the patient had received an unspecified polio vaccine. The patient's mother was unsure if her daughter received the M-M-R II or the unspecified polio vaccine. No product quality complaint was identified. Additional information has been requested.
Injection at 9:30 am on 4/8. Dizziness and euphoria beginning at 1:30 pm, 4 hours post-injection. Dizziness became severe at 5:30 pm, 8 hours post-injection with fever, chills, and nausea. Severe headache beginning at 7:30 pm, 10 hours post-injection, becoming severe migraine headache lasting for 24 hrs until ~7:30 pm on 4/9, 34 hours post-injection. Mild headache persisted until 2:00 am on 4/10, 40.5 hours post-injection.
Initial reaction was normal on May 6; arm became sore quicker than first dose; fever developed 8 hours and lasted on and off until May 8. On May 8th, mild to moderate chest pain and headache developed and lasted through May 10th. On May 11th, I woke up with a heavy head, arms and legs felt very heavy and unusually fatigued. Upon standing and walking down the stairs, I felt like I wanted to collapse if I bent my knees too much. Right side of my face became slightly desensitized. I was feeling jittery. Tongue became slightly desensitized and I briefly lost my ability to chew and swallow. My mom took me to the hospital as I thought it may had been a stroke. ER saw me in a panicked state and thought it was merely an anxiety reaction, disregarding my chronology of events. They gave me Ativan; my symptoms did not go away and yet I was discharged. May 12th, I had fatigue in my legs and tingling sensations in my right arm. Went to the hospital for an MRI of head to rule out stroke. Fatigue and jitteriness continued through the days; May 17th I had an SVT attack and was taken to the hospital by ambulance. Hospital disregarded my vaccine and previous events, believed it was just dehydration despite my usual consumption of fluid. From May 17 to June 4, I continued to experience fatigue in my limbs (limbs felt weak and heavy), tingling sensations, and occasional desensitization in my face in addition to an abnormally high rapid resting heart rate (100s) which would quickly go up with simply tasks like getting a glass of water. On June 4, I woke up and nearly felt all better. From around June 4 to July 6, almost all symptoms disappeared except for an occasional rapid heart rate and a slip of the leg a few times a day when I would walk. After attempting to resume normal activities, by symptoms returned in early July: rapid heart rate, fatigue in my legs and arms, tingling sensations, occasional desensitization of the right side of my face, jitteriness, and abnormal motor functions. The symptoms the second time around have not been as severe as the first round. I also have developed unusual nerve pinching sensations, an feelings of numbness in my legs, pins and needles. Sometimes I get a sudden feeling of a loss of energy. There is a nearly constant feeling of pressure along both sides of my head. All these symptoms appear to flare up and go down a few times a day.
Woke up at 05:00, the following morning, having seizures. Could not control his arms and hands. Has never seized that violently before. Took him to ER by 06:00. Had blood test and given Valium.
This may be nothing as it's pretty weird and unusual.  My sense of smell seems to have increased quite a bit after I received the Moderna shot and has not yet gone away.  I'm just reporting this in case others notice this also.  It's not a bad symptom unless I smell something unpleasant.
Initial information received on 14-Sep-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 58 years old female patient who experienced a large red area was warm and extremely painful, while she received vaccine ADACEL. The patients past medical history, concomitant medication and family history were not provided. On 31-Jan-2018, the patient received injection of suspect ADACEL lot U5726AA, expiry date and dose not provided via intramuscular route in the right deltoid. On an unknown date, the patient developed a non-serious a large red area was warm and extremely painful (vaccination site inflammation) with unknown latency following the administration of ADACEL. The ended up having to seek medical attention that weekend. Lab data was not provided. Final diagnosis was a large red area was warm and extremely painful. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for a large red area was warm and extremely painful. List of documents held by sender- none.
I have Hashimoto's, an autoimmune thyroid disease. The symptoms of it started two months after receiving several vaccines before traveling in 2004. My immune system is reactive to a lot of things.  The first couple days after the COVID-19 vaccine, I was very sick.  I had a 102 fever, body and bone aches, chills, severe headache, etc.  Then I was extremely fatigued for three weeks. Then I had an autoimmune flare-up, which I hadn't had in a few years.  I started to feel speedy, which is common with a Hashimoto's flareup.    What was unusual is that I continued to feel speedy for weeks, to the point that I cut out my thyroid medication (levothyroxine) for two full weeks.  I was speedy, light-headed, heart palpitations, etc.  Every time I tried to take my thyroid medication again, I?d feel super speedy and have to stop.  It took a year to recalibrate my thyroid medication.  In conjunction with that, last year, a couple months after the vaccine, I started to have pressure in my chest.  I have since had multiple appointments and labs with a cardiologist and pulmonologist, and am about to see a rheumatologist.  The cardiologist diagnosed a Pericardial Effusion.  It is not responding to standard drugs.  It is looking like it is pericarditis.  I have constant pressure, achiness and constriction in my chest.
neck pain; redness; swelling that went up her left side; eye droop; This case was reported by a nurse via sales rep and described the occurrence of neck pain in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th July 2019, the patient received the 1st dose of Shingrix. In July 2019, less than a week after receiving Shingrix, the patient experienced neck pain, erythema, swelling and ptosis. On an unknown date, the outcome of the neck pain, erythema, swelling and ptosis were unknown.   It was unknown if the reporter considered the neck pain, erythema, swelling and ptosis to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix on left side and went to the emergency room (ER) complaining of left side eye droop and neck pain. The patient also has redness and swelling that went up her left side. The patient was not sure if the events were related to the Shingrix and she would like any information regarding Shingrix in relation to Bell's palsy.
She was under the weather and did not sleep good; This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY SLEEP (She was under the weather and did not sleep good) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 039B21A) for COVID-19 vaccination.     Patient never had a positive COVID-19 test or diagnosis.  The patient's past medical history included Tetanus. Concurrent medical conditions included Penicillin allergy. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), LISINOPRIL and AMLODIPINE for Blood pressure management.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced POOR QUALITY SLEEP (She was under the weather and did not sleep good). At the time of the report, POOR QUALITY SLEEP (She was under the weather and did not sleep good) outcome was unknown.            The patient stated that she was ok with the first 2 doses of the Moderna covid-19 vaccine and was reported that the patient was under the weather and did not sleep good. No treatment received.   This case was linked to MOD-2022-543447, MOD-2022-543464 (Patient Link).
This case was reported by a physician via sales rep and described the occurrence of erythema of extremities in a adult female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was unknown. It was unknown if the reporter considered the erythema of extremities to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional showed a picture of patient's erythema on arm post administration. The patient experienced redness over entire back of arm (possibly left arm, judging by picture). The health care professional did not want to file adverse event report before asking the patient first. The information regarding the administration, patient and vaccine were unknown. The reporter did not agree to be followed up from safety department. This case had been linked with US2018GSK093084, reported by the same reporter.
Lower back pain/stiffness.  Hurt most when sitting.  Standing and walking did not hurt.  The pain lasted about 12 hours. Took 2 tablets of naproxen sodium upon onset of pain.
Worsening respiratory symptoms developed pleural effusion/pericardial effusion requiring thoracentesis and pericardiocentesis.
pt recv vax then went to lay down;awoke w/extreme GI upset;this cont for about 6hr
11FEB97 occasional loose cough;inc temp 99.9, lethargic;12FEB97 t100.4, cough 13FEB97 t102.5;med given 3FEB97 until 12FEB97;12FEB97 positive influenza A type a isolated;